Let’s celebrate – thanks to the EU funding we are on a global market!

For the past two years, Enantis has worked under the prestigious EU grant SME Instrument. We are one of the two Czech companies that were awarded Phase II funding and the only biotech company. For this reason, Enantis is extremely proud to announce that the project was successfully finished and evaluated by the experts and the results are just magnificent. Well, read the first sentence of our evaluation report for yourself:

„Project has delivered exceptional results with significant immediate or potential impact“

The SME Instrument provided us with structure, funds, and advice necessary to develop and launch our exquisite product globally. The FGF2-STAB, hyperstable fibroblast growth factor 2, is now being sold worldwide and we receive just positive feedback. (By the way, let us know if you want to buy it, we will point you in the direction of our distributor).

This is not the end though, we are already on a mission to stabilise more molecules to be used in stem cell cultivation and tissue regeneration.

Stay tuned !!!